JP2024546944A5 - - Google Patents

Info

Publication number
JP2024546944A5
JP2024546944A5 JP2024535917A JP2024535917A JP2024546944A5 JP 2024546944 A5 JP2024546944 A5 JP 2024546944A5 JP 2024535917 A JP2024535917 A JP 2024535917A JP 2024535917 A JP2024535917 A JP 2024535917A JP 2024546944 A5 JP2024546944 A5 JP 2024546944A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
heterocyclyl
halogen
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546944A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081514 external-priority patent/WO2023114818A1/en
Publication of JP2024546944A publication Critical patent/JP2024546944A/ja
Publication of JP2024546944A5 publication Critical patent/JP2024546944A5/ja
Pending legal-status Critical Current

Links

JP2024535917A 2021-12-15 2022-12-14 Ｒｘｆｐ１アゴニストとしてのナフタレンおよびキノリン類似体 Pending JP2024546944A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289822P 2021-12-15 2021-12-15
US63/289,822 2021-12-15
PCT/US2022/081514 WO2023114818A1 (en) 2021-12-15 2022-12-14 Naphthalene and quinoline analogs as rxfp1 agonists

Publications (2)

Publication Number Publication Date
JP2024546944A JP2024546944A (ja) 2024-12-26
JP2024546944A5 true JP2024546944A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=85227073

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535917A Pending JP2024546944A (ja) 2021-12-15 2022-12-14 Ｒｘｆｐ１アゴニストとしてのナフタレンおよびキノリン類似体

Country Status (6)

Country Link
US (1) US20250100960A1 (cg-RX-API-DMAC7.html)
EP (1) EP4448504A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546944A (cg-RX-API-DMAC7.html)
KR (1) KR20240122836A (cg-RX-API-DMAC7.html)
CN (1) CN118414330A (cg-RX-API-DMAC7.html)
WO (1) WO2023114818A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9452973B2 (en) * 2012-05-04 2016-09-27 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Modulators of the relaxin receptor 1

Similar Documents

Publication Publication Date Title
JP2024540164A5 (cg-RX-API-DMAC7.html)
JP2024540163A5 (cg-RX-API-DMAC7.html)
JP5337479B2 (ja) 新規化合物
JP2024546943A5 (cg-RX-API-DMAC7.html)
JP2018508569A5 (cg-RX-API-DMAC7.html)
JP2012522759A5 (cg-RX-API-DMAC7.html)
JP2010526145A5 (cg-RX-API-DMAC7.html)
JP2020526484A5 (cg-RX-API-DMAC7.html)
RU2006112428A (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
JP2009108048A (ja) 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製
JP2006265257A (ja) Ｖｃａｍ−１発現を阻害する化合物および方法
JP2014513046A (ja) ４−ヒドロキシ酪酸の重水素化類似体
JP2023535453A5 (cg-RX-API-DMAC7.html)
JP2024546944A5 (cg-RX-API-DMAC7.html)
AU2006236534A1 (en) Methods of increasing natural killer cell activity for therapy
JP2022530051A5 (cg-RX-API-DMAC7.html)
US20060106082A1 (en) Nitrooxyderivatives of cyclooxygenase-2 inhibitors
US5686621A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
JP6454335B2 (ja) カテプシンシステインプロテアーゼ阻害剤
JP2024546946A5 (cg-RX-API-DMAC7.html)
JP3110515B2 (ja) スルホンアミド誘導体
JP2022537350A5 (cg-RX-API-DMAC7.html)
JP2024540161A5 (cg-RX-API-DMAC7.html)
JP2021520394A5 (cg-RX-API-DMAC7.html)
JP2025503442A5 (cg-RX-API-DMAC7.html)